Emerging Role of Garcinol in Targeting Cancer Stem Cells of Non-small Cell Lung Cancer

被引：5
作者：
Wang L. [1 ]
Wang M. [1 ]
Guo H. [2 ]
Zhao H. [1 ]
机构：
[1] Tianjin Key Laboratory of Food and Biotechnology, Food Science Division, School of Biotechnology and Food Science, Tianjin University of Commerce, No. 409 Guangrong Rd., Beichen District, Tianjin
[2] Department of Biotherapy, Third Central Hospital of Tianjin Medical University, Tianjin
来源：
Current Pharmacology Reports | 2019年 / 5卷 / 1期
基金：
中国国家自然科学基金;
关键词：
Anticancer; Cancer stem cells; Garcinol; Non-small cell lung cancer; Structure-activity relationship;
D O I：
10.1007/s40495-019-00169-6
中图分类号：
学科分类号：
摘要：
Garcinol is a polyisoprenylated benzophenone analogue primarily isolated from the dried rind of Garcinia indica, a tropical fruit widely grown in Southeast Asia and Central Africa. Recent findings have well documented that garcinol is a potential dietary phytochemical candidate in the prevention and treatment of cancer and oxidative-related illness. Herein, a brief structure-activity relationship (SAR) is summarized in this review to disclose the connection between the chemical structure of garcinol and its biological activity. Non-small cell lung cancer (NSCLC) is a predominant type of lung cancer, exhibiting an extremely high mortality rate as a result of failing to clean up cancer stem cells (CSCs). Interestingly, garcinol was reported to be able to target and suppress CSCs, and both in vitro and in vivo evidences have revealed the outstanding anti-NSCLC potential of garcinol. The mechanism may involve cellular senescence and apoptosis induction, as well as cell cycle arrest. This paper will review the current progress of garcinol against various tumors in vitro and in vivo, particularly the effects on NSCLC, and summarize the critical structural features of garcinol as a potent anticancer candidate. Also, we will discuss potential future challenges in research and development of garcinol. © 2019, Springer Nature Switzerland AG.
引用
收藏
页码：14 / 19
页数：5
相关论文
共 53 条
  • [1] Torre L.A., Siegel R.L., Ward E.M., Jemal A., Global cancer incidence and mortality rates and trends--an update, Cancer Epidemiol Biomark Prev, 25, 1, pp. 16-27, (2016)
  • [2] Torre L.A., Bray F., RL Siegel J., Ferlay J., Lortet-Tieulent A.J., Global cancer statistics, 2012, CA Cancer J Clin, 65, 2, pp. 87-108, (2015)
  • [3] Hu Y., Fu L., Targeting cancer stem cells: a new therapy to cure cancer patients, Am J Cancer Res, 2, 3, pp. 340-356, (2012)
  • [4] Khan S., Karmokar A., Howells L., Thomas A.L., Bayliss R., Gescher A., Et al., Targeting cancer stem-like cells using dietary-derived agents - where are we now?, Mol Nutr Food Res, 60, 6, pp. 1295-1309, (2016)
  • [5] Dandawate P.R., Subramaniam D., Jensen R.A., Anant S., Targeting cancer stem cells and signaling pathways by phytochemicals: novel approach for breast cancer therapy, Semin Cancer Biol, 40-41, pp. 192-208, (2016)
  • [6] Knobloch T.J., Uhrig L.K., Pearl D.K., Casto B.C., Warner B.M., Clinton S.K., Et al., Suppression of proinflammatory and prosurvival biomarkers in oral cancer patients consuming a black raspberry phytochemical-rich troche, Cancer Prev Res (Phila), 9, 2, pp. 159-171, (2016)
  • [7] Marventano S., Salomone F., Godos J., Pluchinotta F., Del Rio D., Mistretta A., Et al., Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies, Clin Nutr, 35, 6, pp. 1269-1281, (2016)
  • [8] Braakhuis A.J., Campion P., Bishop K.S., Reducing breast cancer recurrence: the role of dietary polyphenolics, Nutrients, 8, 9, (2016)
  • [9] Yamaguchi F., Ariga T., Yoshimura Y., Nakazawa H., Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind, J Agric Food Chem, 48, 2, pp. 180-185, (2000)
  • [10] Krishnamurthy N., Lewis Y.S., Ravindranath B., On the structures of garcinol, isogarcinol and camboginol, Tetrahedron Lett, 22, 8, pp. 793-796, (1981)
123456